1 – 7 of 7
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2020
- Why Is Amyloid-β PET Requested After Performing CSF Biomarkers?
- 2019
- Cognitive reserve and clinical progression in Alzheimer disease : A paradoxical relationship
- Assessment of the appropriate use criteria for amyloid PET in an unselected memory clinic cohort : The ABIDE project
- Applying the ATN scheme in a memory clinic population : The ABIDE project
- 2018
- Is intracranial volume a suitable proxy for brain reserve? Rik Ossenkoppele
- Clinical phenotype, atrophy, and small vessel disease in APOEε2 carriers with Alzheimer disease
- Prevalence of the apolipoprotein E ε4 allele in amyloid β positive subjects across the spectrum of Alzheimer's disease